摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,6-dimethoxy-3’-hydroxyaurone | 108974-63-6

中文名称
——
中文别名
——
英文名称
4,6-dimethoxy-3’-hydroxyaurone
英文别名
4,6-dimethoxy-2-(3'-hydroxybenzylidene)benzofuran-3(2H)-one;(Z)-2-(3-hydroxybenzylidene)-4,6-dimethoxybenzofuran-3(2H)-one;2-((Z)-3-hydroxy-benzylidene)-4,6-dimethoxy-benzofuran-3-one;2-((Z)-3-Hydroxy-benzyliden)-4,6-dimethoxy-benzofuran-3-on;(2Z)-2-[(3-hydroxyphenyl)methylene]-4,6-dimethoxy-benzofuran-3-one;(2Z)-2-[(3-hydroxyphenyl)methylidene]-4,6-dimethoxy-1-benzofuran-3-one
4,6-dimethoxy-3’-hydroxyaurone化学式
CAS
108974-63-6
化学式
C17H14O5
mdl
——
分子量
298.295
InChiKey
SCNQRHDLSSRVEK-CHHVJCJISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    以Aurones为效应子研究蘑菇和细菌酪氨酸酶之间的结合位同源性
    摘要:
    更光明的未来: Aurones已被确定为黑色素生物合成的抑制剂。在这项研究中,对蘑菇和细菌酪氨酸酶(TyM和TyB)上的24种金质进行了评估。该化合物充当两种酶的抑制剂,底物或激活剂。我们的结果强调了在同一分子下TyM和TyB之间行为的异同。
    DOI:
    10.1002/cbic.201402003
  • 作为产物:
    描述:
    2-氯-1-(2,4,6-三羟基苯基)乙酮sodium methylatepotassium carbonate 、 potassium hydroxide 作用下, 以 甲醇乙二醇二甲醚 为溶剂, 反应 4.5h, 生成 4,6-dimethoxy-3’-hydroxyaurone
    参考文献:
    名称:
    Discovery of Naturally Occurring Aurones That Are Potent Allosteric Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase
    摘要:
    We have identified naturally occurring 2-benzylidenebenzofuran-3-ones (aurones) as new templates for non-nucleoside hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors. The aurone target site, identified by site-directed mutagenesis, is located in thumb pocket I of HCV RdRp. The RdRp inhibitory activity of 42 aurones was rationally explored in an enzyme assay. Molecular docking studies were used to determine how aurones bind to HCV RdRp and to predict their range of inhibitory activity. Seven aurone derivatives were found to have potent inhibitory effects on HCV RdRp, with IC(50) below 5 mu M and excellent selectivity index (inhibition activity versus cellular cytotoxicity). The most active aurone analogue was (Z)-2-((1-butyl-1H-indo1-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one (compound 51), with an IC(50) of 2.2 mu M. Their potent RdRp inhibitory activity and their low toxicity make these molecules attractive candidates as direct-acting anti-HCV agents.
    DOI:
    10.1021/jm200242p
点击查看最新优质反应信息

文献信息

  • Synthesis of structurally diverse biflavonoids
    作者:Tze Jing Sum、Tze Han Sum、Warren R.J.D. Galloway、David G. Twigg、Joe J. Ciardiello、David R. Spring
    DOI:10.1016/j.tet.2018.05.003
    日期:2018.9
    a growing interest in synthetic approaches that can provide access to structurally novel biflavonoids so that the biological usefulness of this compound class can be more fully investigated. Herein, we report upon the exploration of strategies based around Suzuki-Miyaura cross-coupling and alcohol methylenation for the synthesis of two classes of biflavonoids: (i) rare ‘hybrid’ derivatives containing
    合成的双黄酮类化合物与有趣的生物学活性有关,但在药物发现中仍缺乏很好的探索。近年来,目睹了对合成方法的日益增长的兴趣,这些方法可以提供结构新颖的双黄酮类化合物,因此可以更充分地研究此类化合物的生物学用途。在本文中,我们报告了基于铃木-宫浦交叉偶联和醇甲基化的策略,用于合成两类双黄酮类化合物:(i)含有属于不同亚类的类黄酮单体的稀有“杂化”衍生物,以及(ii)同二聚体化合物,其中两个类黄酮单体通过亚甲二氧基连接。
  • Synthesis of Flavonols via Pyrrolidine Catalysis: Origins of the Selectivity for Flavonol versus Aurone
    作者:Wei Xiong、Xiaohong Wang、Xianyan Shen、Cuifang Hu、Xin Wang、Fei Wang、Guolin Zhang、Chun Wang
    DOI:10.1021/acs.joc.0c01869
    日期:2020.10.16
    method for flavonol from 2′-hydroxyl acetophenone and benzaldehyde promoted by pyrrolidine under an aerobic condition in water is established. This protocol was supported by efficient synthesis of 44 common examples and three natural products. The α, β-unsaturated iminium ion (enimine ion E) was proved to be the key intermediate in the reaction. H218O and 18O2 isotope tracking experiments demonstrated
    建立了一种在水中好氧条件下由吡咯烷促进的2'-羟基苯乙酮和苯甲醛合成黄酮醇的新方法。该协议得到44个常见实例和三种天然产物的有效合成的支持。事实证明,α,β-不饱和亚胺离子(亚胺离子E)是反应的关键中间体。H 2 18 O和18 O 2同位素跟踪实验表明,水和好氧气氛对于确保转化都必不可少。黄酮醇或金酮的选择性源自溶剂触发的中间体,该中间体由分离的亚胺的紫外可见光谱确定。酚亚胺EA在水中占主导地位,酮烯胺中间体EB在乙腈中盛行。在环化和[2 + 2]氧化的关键步骤之后,在吡咯烷和氧的存在下,EA通过EI(两性离子样的酚氧基亚胺离子)通过EI生成黄酮醇。EB通过路径II进行,这是由EB与吡咯烷和氧气共同光解而引发的自由基过程,从而生成金酮。初步的机械研究报道。
  • Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein)
    作者:Hong-May Sim、Chong-Yew Lee、Pui Lai Rachel Ee、Mei-Lin Go
    DOI:10.1016/j.ejps.2008.07.008
    日期:2008.11
    their ability to modulate ABCG2 (breast cancer resistance protein)-mediated multidrug resistance in vitro. Several members (0.5 microM) increased the accumulation of mitoxantrone (MX) in human breast cancer cells (MDA-MB-231) transfected with ABCG2 and re-sensitized these cells to the cytotoxic effects of MX. In the re-sensitization assay, aurones at 0.5 microM reduced the resistance of the transfected
    通过将4,6-二甲氧基苯并呋喃-3(2H)-1与各种苯甲醛在碱催化的醛醇缩合反应中反应,合成了一系列4,6-二甲氧基金错误。根据光谱和晶体学数据将AZ构型分配给了光环。测试了金黄色素在体外调节ABCG2(乳腺癌抗性蛋白)介导的多药抗性的能力。几个成员(0.5 microM)增加了用ABCG2转染的人乳腺癌细胞(MDA-MB-231)中米托蒽醌(MX)的积累,并使这些细胞对MX的细胞毒性作用重新敏感。在再敏化试验中,0.5 microM的金黄色素使转染细胞对MX的抗性降至亲代细胞的两倍,超过在相同浓度下测试的泛黄霉素C(FTC)。金黄色素(10 microM)还增加了钙黄绿素-AM在用ABCB1(P-糖蛋白)转染的MDCKII / MDR1细胞中的蓄积,其水平与在相同浓度下测试的维拉帕米相当。结构活性分析表明,对于ABCG2抑制作用,金质模板中亚苄基环B的取代作用不那么重要,对于具有未取代环
  • Functionalized aurones as inducers of NAD(P)H:quinone oxidoreductase 1 that activate AhR/XRE and Nrf2/ARE signaling pathways: Synthesis, evaluation and SAR
    作者:Chong-Yew Lee、Eng-Hui Chew、Mei-Lin Go
    DOI:10.1016/j.ejmech.2010.03.023
    日期:2010.7
    The chemopreventive potential of functionalized aurones and related compounds as inducers of NAD(P) H:quinone oxidoreductase 1 (NQO1, EC 1.6.99.2) are described. Several 4,6-dimethoxy and 5-hydroxyaurones induced NQO1 activity of Hepa1c1c7 cells by 2-fold at submicromolar concentrations, making these the most potent inducers to be identified from this class. Mechanistically, induction of NQO1 was mediated by the activation of AhR/XRE and Nrf2/ARE pathways, indicating that aurones may be mixed activators of NQO1 induction or agents capable of exploiting the proposed cross-talk between the AhR and Nrf2 gene batteries. QSAR analysis by partial least squares projection to latent structures (PLS) identified size parameters, in particular those associated with non-polar surface areas, as an important determinant of induction activity. These were largely determined by the substitution on rings A and B. A stereoelectronic role for the exocyclic double bond as reflected in the E-LUMO term was also identified. The electrophilicity of the double bond or its effect on the conformation of the target compound are possible key features for induction activity. (c) 2010 Elsevier Masson SAS. All rights reserved.
  • DiVittorio, Rendiconti - Istituto superiore di sanita, 1958, vol. 21, p. 418,428
    作者:DiVittorio
    DOI:——
    日期:——
查看更多

同类化合物

降钙素 金色草素 苦杏碱醇B 海生菊甙 噢弄斯定 E-2-[(4-甲氧基苯基)亚甲基]苯并[b]呋喃-3-酮 6-羟基-2-[羟基-(4-羟基苯基)甲基]-1-苯并呋喃-3-酮 6,4''-二羟基橙酮 5-乙酰基-2-苯甲酰基-1-苯并呋喃-3-酮 3(2H)-苯并呋喃酮,4,6-二羟基-2-[(4-羟基苯基)亚甲基]-,(2Z)- 3',5'-二溴-2',4,4',6-四羟基橙酮 2-苯甲酰基-6-甲氧基-1-苯并呋喃-3-酮 2-苯甲酰基-5-甲基-1-苯并呋喃-3-酮 2-苯甲酰基-1-苯并呋喃-3(2H)-酮 2-苯甲酰-2-羟基-1-苯并呋喃-3-酮 2-氨基-6-氯-3-硝基吡啶 2-氨基-2-苄基-1-苯并呋喃-3-酮 2-[(Z)-(3,4-二羟基苯基)亚甲基]-6-羟基-7-甲氧基苯并呋喃-3(2H)-酮 2-[(4-羟基-3-甲氧基苯基)亚甲基]-7-甲氧基-1-苯并呋喃-3-酮 2-[(4-硝基苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(4-甲氧基苯基)亚甲基]-5-甲基-1-苯并呋喃-3-酮 2-[(4-溴苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(4-氟苯基)亚甲基]-6-羟基-1-苯并呋喃-3-酮 2-[(4-氟苯基)亚甲基]-6-甲氧基-1-苯并呋喃-3-酮 2-[(4-氟苯基)亚甲基]-5-甲基-1-苯并呋喃-3-酮 2-[(3-甲氧基苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(3-甲基苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(3,4-二甲氧基苯基)亚甲基]-1-苯并呋喃-3-酮 2-(4-甲氧基苯甲酰基)-1-苯并呋喃-3-酮 2-(3,4-二羟基苯甲酰)-2,4,6-三羟基-1-苯并呋喃-3-酮 2-(3,4-二羟基苯亚甲基)-6-羟基-3(2H)-苯并呋喃酮 2-(3,4-二羟基亚苄基)苯并呋喃-3(2H)-酮 1H-萘并[2,1-b]吡喃-2-甲腈,3-氨基-1-(2-氟苯基)- 1,1-二甲基铟烷-5,6-二醇 1,1,2-三甲基肼二盐酸 (Z)-4,6-二羟基橙酮 (7Z)-4-羟基-7-(苯基甲亚基)呋喃并[3,2-e][1,3]苯并二噁唑-8(7H)-酮 (2Z)-4,6-二羟基-2-[(3,4,5-三羟基苯基)亚甲基]-1-苯并呋喃-3-酮 (2E)-2-[(3-硝基苯基)亚甲基]-1-苯并呋喃-3-酮 2-((Z)-2,4-dimethoxy-benzylidene)-5-methyl-benzofuran-3-one (2Z)-5-[(dimethylamino)methyl]-6-hydroxy-2-(4-methoxybenzylidene)-7-methyl-1-benzofuran-3(2H)-one (2Z)-2-(2,4-dimethoxybenzylidene)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]methyl}-1-benzofuran-3(2H)-one (2Z)-2-(3,4-dimethoxybenzylidene)-5-[(dimethylamino)-methyl]-6-hydroxy-7-methyl-1-benzofuran-3(2H)-one (Z)-2-(2,4-dimethoxybenzylidene)-6-hydroxybenzofuran-3(2H)-one (2Z)-6-hydroxy-2-(4-methoxybenzylidene)-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]methyl}-1-benzofuran-3(2H)-one (2Z)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]-methyl}-2-(3,4,5-trimethoxybenzylidene)-1-benzofuran-3(2H)-one (2Z)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]-methyl}-2-(2,3,4-trimethoxybenzylidene)-1-benzofuran-3(2H)-one (2Z)-2-(2,3-dimethoxybenzylidene)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]methyl}-1-benzofuran-3(2H)-one (Z)-2-(2-hydroxy-3-methoxybenzylidene)benzofuran-3(2H)-one (Z)-2-(4-bromobenzylidene)-6-hydroxy-7-methylbenzofuran-3(2H)-one